32 results
Page 2 of 2
424B5
oqkxebfs3rmjl
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
0hze6u y8ps
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
urfegg
13 Nov 20
Moleculin Biotech, Inc. Reports Financial Results
7:29am
424B5
xktzrz1ri4puhxsx0os
12 Nov 20
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
jfh2mc23rq1yzyiw
12 Aug 20
Results of Operations and Financial Condition
7:32am
8-K
EX-99.1
9lyckl14
15 Jul 20
Moleculin Announces Agreement to Produce WP1122 for Expanded Development of Potential COVID-19 and Oncology Drug Candidate
7:30am
DEFA14A
7i9c81da63qazn4m
15 May 20
Additional proxy soliciting materials
4:00pm